BrainStorm Cell Therapeutics
BCLI
#10103
Rank
A$11.35 M
Marketcap
$1.74
Share price
14.87%
Change (1 day)
-85.94%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of December 2024 : A$1.11 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is A$1.11 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2024)

Total debt by year

Year Total debt Change
2022-12-31A$6.01 M-14.15%
2021-12-31A$7 M-25.36%
2020-12-31A$9.38 M177.74%
2019-12-31A$3.37 M
2018-12-31N/A
2010-12-31A$0.13 M-67.25%
2009-12-31A$0.41 M-34.4%
2008-12-31A$0.62 M-64.38%
2007-12-31A$1.76 M23.4%
2006-12-31A$1.42 M
2006-03-31A$0.7 M
2004-03-31A$0.04 M18.24%
2003-03-31A$0.03 M83.42%
2002-03-31A$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$41.51 B 3,709,761.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.22 B 109,438.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.17 B 15,662.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.30 B 920,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B 13,076.39%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA